ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
2.070
+0.140 (7.25%)
At close: Sep 3, 2025, 4:00 PM
2.130
+0.060 (2.90%)
After-hours: Sep 3, 2025, 7:52 PM EDT
ImmunoPrecise Antibodies Market Cap
ImmunoPrecise Antibodies has a market cap or net worth of $95.54 million as of September 3, 2025. Its market cap has increased by 247.41% in one year.
Market Cap
95.54M
Enterprise Value
97.52M
1-Year Change
247.41%
Ranking
Category
Stock Price
$2.07
Market Cap Chart
Since December 31, 2020, ImmunoPrecise Antibodies's market cap has decreased from $250.60M to $95.54M, a decrease of -61.88%. That is a compound annual growth rate of -18.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2025 | 95.50M | 752.68% |
| Dec 31, 2024 | 11.20M | -73.83% |
| Dec 29, 2023 | 42.80M | -67.05% |
| Dec 30, 2022 | 129.90M | 25.14% |
| Dec 31, 2021 | 103.80M | -58.58% |
| Dec 31, 2020 | 250.60M | - |
| Dec 31, 2020 | 250.60M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.38B |
| Johnson & Johnson | 428.68B |
| AbbVie | 374.26B |
| UnitedHealth Group | 278.84B |
| AstraZeneca | 254.65B |
| Novo Nordisk | 253.55B |
| Novartis AG | 248.54B |
| Abbott Laboratories | 230.05B |